Real-time enrollment status for this progressive supranuclear palsy richardson syndrome (psp-rs) clinical trial
Current Status
Recruiting
Checked: October 16, 2026 at 8:04 PM UTC
| NCT Number | NCT07498426 |
| Recruiting Status | Recruiting |
| Condition | Progressive Supranuclear Palsy Richardson Syndrome (PSP-RS) |
| Phase | PHASE3 |
| Target Enrollment | 300 participants |
| Active Locations | 9 sites in the US |
| Sponsor | Novartis Pharmaceuticals |
| Last Updated on CT.gov | October 15, 2026 (Yesterday) |
As of October 16, 2026: Clinical trial NCT07498426 is currently recruiting participants. This phase3 study for progressive supranuclear palsy richardson syndrome (psp-rs) is actively seeking new participants at 9 locations across the United States. The study is sponsored by Novartis Pharmaceuticals. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07498426 is actively recruiting participants as of October 16, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 9 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07498426 was last updated Yesterday (October 15, 2026). HelloStudys verifies this status automatically.